COMMUNIQUÉS West-GlobeNewswire

-
Veloxis Announces the Total Number of Shares and Voting Rights in the Company as of 31 December 2017
31/12/2017 -
Helius Medical Technologies Announces Closing of Final Tranche of Private Placement
30/12/2017 -
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
30/12/2017 -
SELLAS Life Sciences Group Successfully Completes Business Combination with Galena Biopharma
29/12/2017 -
Edge's EG-1962 Phase 3 NEWTON 2 Study Continues as Planned Following Completion of Futility Analysis
29/12/2017 -
Bio-Path Holdings Provides Clinical Update and 2018 Business Outlook
29/12/2017 -
Medovex Corporation Converts IDE Submission to a Pre-Submission with Food and Drug Administration for its DenerveX System
29/12/2017 -
ContraVir Pharmaceuticals Announces John Sullivan-Bolyai, M.D., MPH Steps Down as Chief Medical Officer
29/12/2017 -
United American Healthcare Corporation’s Subsidiaries show strong Third Quarter Fiscal Year 2017 Results
29/12/2017 -
Repligen To Present at 36th Annual J.P. Morgan Healthcare Conference
29/12/2017 -
Veloxis Pharmaceuticals Announces Financial Calendar for 2018
29/12/2017 -
Medtronic Chairman and CEO Omar Ishrak to Speak at J.P. Morgan Healthcare Conference
29/12/2017 -
Saniona AB: Saniona Establish Equity Financing of up to SEK 144 million
29/12/2017 -
Canada House Wellness Group Announces The Retirement of Interim CEO Gerry Goldberg
29/12/2017 -
Galena Biopharma, Inc. Stockholders Approve Business Combination with SELLAS Life Sciences Group, Ltd; Board Sets Reverse Stock Split Ratio
29/12/2017 -
Alpha Pro Tech, Ltd. Names Lloyd Hoffman as President; Appoints Donna Millar to Board of Directors
29/12/2017 -
Delcath Announces Exit from Convertible Note
29/12/2017 -
Progenics Pharmaceuticals Announces FDA Acceptance of New Drug Application for AZEDRA® (iobenguane I 131) in Pheochromocytoma and Paraganglioma
29/12/2017 -
Hemispherx Biopharma, Inc. to Present at Biotech Showcase™ 2018
29/12/2017
Pages